Rapid reinfection by Giardia lamblia after treatment in a hyperendemic area: the case against treatment
AbstractWe selected 405 children aged 1-10 years with Giardia lamblia infection but without abdominal or gastrointestinal complaints for the previous month. For 5 days, 204 received metronidazole 15 mg/kg/day and 201 received B-complex syrup. Stool samples were examined 2-3 weeks and 3 months after treatment and results were tested with chi-squared. Weight and height 6 months after treatment were compared with primary weight and height by Z-score and Student t-test. Metronidazole efficacy at 2-3 weeks was 85.3%. Three months after treatment, 60 were reinfected [34.5%] and 71 had spontaneously cleared [35.3%]. Because of high reinfection, spontaneous clearing and treatment failure rates, and the lack of effect on nutritional status or growth, we do not recommend treatment for children with asymptomatic giardia infection
Saffar, M.J., Qaffari, J., Khalilian, A.R. & Kosarian, M. (2005). Rapid reinfection by Giardia lamblia after treatment in a hyperendemic area: the case against treatment. EMHJ - Eastern Mediterranean Health Journal, 11 (1-2), 73-78, 2005 http://www.who.int/iris/handle/10665/116921
JournalEMHJ - Eastern Mediterranean Health Journal, 11 (1-2), 73-78, 2005
MetadataShow full item record
Showing items related by title and MeSH subject.
Treatment and care for HIV-positive injecting drug users: Module 8 - Treatment and care for HIV-positive injecting drug users World Health Organization, Regional Office for South-East Asia (2007)The "Treatment and Care for HIV-Positive Injecting Drug Users" training curriculum is designed for clinicians who provide treatment and care, including ART, for HIV-positive injecting drug users. The training curriculum consists of a trainer manual, 12 participant manuals, and a CD-ROM with PowerPoint presentations and reference articles. Topics covered in the curriculum include: Module 1: Drug use and HIV in Asia Module 2: Comprehensive services for injecting drug users Module 3: Initial patient assessment Module 4: Managing opioid dependence ...